Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Peters

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
HIV Clinical Trials|April 14, 2009
Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, SpainVincent Soriano, Marion Peters, Juergen Rockstroh
Hepatology International|August 12, 2009
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategiesGeorge Lau, Patrick Marcellin, Marion Peters
Hepatology (Baltimore, Md.)|June 1, 2007
HIV and liver disease forum: conference proceedingsKenneth E Sherman, Marion Peters, Margaret James Koziel
The New England Journal of Medicine|March 2, 2017
Histology Rings TrueRabih Geha, Marion Peters, Ryan M Gill, et al.
Neuropsychobiology|February 5, 2003
The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitroSebastian Rudolf, Marion Peters, Matthias Rothermundt, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Risk factors for hepatitis B infection in rural VietnamThai Hong Duong, Phuong Hong Nguyen, Keith Henley, et al.
Microscopy Research and Technique|March 20, 2003
S100B in brain damage and neurodegenerationMatthias Rothermundt, Marion Peters, Jochen H M Prehn, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 30, 2004
Search for atypical lymphocytes in schizophreniaSebastian Rudolf, Peter Schlenke, Andreas Broocks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2018
Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing TherapyAni Kardashian, Jeff McKinney, Nina Huynh, et al.
AIDS (London, England)|August 26, 2011
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patientsVincent Soriano, Kenneth E Sherman, Juergen Rockstroh, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
HIV Clinical Trials|April 14, 2009
Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, SpainVincent Soriano, Marion Peters, Juergen Rockstroh
Hepatology International|August 12, 2009
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategiesGeorge Lau, Patrick Marcellin, Marion Peters
Hepatology (Baltimore, Md.)|June 1, 2007
HIV and liver disease forum: conference proceedingsKenneth E Sherman, Marion Peters, Margaret James Koziel
The New England Journal of Medicine|March 2, 2017
Histology Rings TrueRabih Geha, Marion Peters, Ryan M Gill, et al.
Neuropsychobiology|February 5, 2003
The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitroSebastian Rudolf, Marion Peters, Matthias Rothermundt, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Risk factors for hepatitis B infection in rural VietnamThai Hong Duong, Phuong Hong Nguyen, Keith Henley, et al.
Microscopy Research and Technique|March 20, 2003
S100B in brain damage and neurodegenerationMatthias Rothermundt, Marion Peters, Jochen H M Prehn, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 30, 2004
Search for atypical lymphocytes in schizophreniaSebastian Rudolf, Peter Schlenke, Andreas Broocks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2018
Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing TherapyAni Kardashian, Jeff McKinney, Nina Huynh, et al.
AIDS (London, England)|August 26, 2011
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patientsVincent Soriano, Kenneth E Sherman, Juergen Rockstroh, et al.
Pageof 5